Literature DB >> 8548369

The pharmacokinetics and metabolism of SC-53228, a specific leukotriene B4 receptor antagonist.

S Paulson1, Y Readus, S Bulik, G Schoenhard, J Stolzenbach, D Fretland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8548369     DOI： 10.1007/bf01778303

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  5 in total

Review 1.  Interspecies scaling and comparisons in drug development and toxicokinetics.

Authors:  R M Ings
Journal:  Xenobiotica       Date:  1990-11       Impact factor: 1.908

2.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

3.  Leukotriene B4 in atopic dermatitis: increased skin levels and altered sensitivity of peripheral blood T-cells.

Authors:  S Thorsen; K Fogh; U Broby-Johansen; J Søndergaard
Journal:  Allergy       Date:  1990-08       Impact factor: 13.146

Review 4.  Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents.

Authors:  J A Salmon; L G Garland
Journal:  Prog Drug Res       Date:  1991

5.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682
  5 in total
  1 in total

1.  Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents.

Authors:  D J Fretland; C P Anglin; D Widomski; D A Baron; T Maziasz; P F Smith
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.